- Home
- ATXS vs NFE Comparison
ATXS vs NFE Comparison
Compare ATXS & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- NFE
- Stock Information
- Founded
- ATXS 2008
- NFE 2014
- Country
- ATXS United States
- NFE United States
- Employees
- ATXS N/A
- NFE N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- NFE Oil/Gas Transmission
- Sector
- ATXS Health Care
- NFE Utilities
- Exchange
- ATXS Nasdaq
- NFE Nasdaq
- Market Cap
- ATXS 676.1M
- NFE 773.2M
- IPO Year
- ATXS 2015
- NFE 2019
- Fundamental
- Price
- ATXS $12.46
- NFE $1.72
- Analyst Decision
- ATXS Buy
- NFE Strong Buy
- Analyst Count
- ATXS 7
- NFE 5
- Target Price
- ATXS $30.00
- NFE $7.70
- AVG Volume (30 Days)
- ATXS 4.1M
- NFE 11.9M
- Earning Date
- ATXS 11-12-2025
- NFE 12-05-2025
- Dividend Yield
- ATXS N/A
- NFE N/A
- EPS Growth
- ATXS N/A
- NFE N/A
- EPS
- ATXS N/A
- NFE N/A
- Revenue
- ATXS N/A
- NFE $2,006,240,000.00
- Revenue This Year
- ATXS N/A
- NFE $10.40
- Revenue Next Year
- ATXS N/A
- NFE $11.08
- P/E Ratio
- ATXS N/A
- NFE N/A
- Revenue Growth
- ATXS N/A
- NFE N/A
- 52 Week Low
- ATXS $3.56
- NFE $1.26
- 52 Week High
- ATXS $12.55
- NFE $16.66
- Technical
- Relative Strength Index (RSI)
- ATXS 84.72
- NFE 38.70
- Support Level
- ATXS $11.83
- NFE $1.68
- Resistance Level
- ATXS $12.16
- NFE $2.08
- Average True Range (ATR)
- ATXS 0.36
- NFE 0.19
- MACD
- ATXS 0.26
- NFE -0.02
- Stochastic Oscillator
- ATXS 97.97
- NFE 5.92
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.